Optimal Induction of T-Cell Responses against Hepatitis C Virus E2 by Antigen Engineering in DNA Immunization
Open Access
- 1 November 2003
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 77 (21) , 11596-11602
- https://doi.org/10.1128/jvi.77.21.11596-11602.2003
Abstract
Although DNA immunization is a safe and efficient method for inducing cellular immune responses, it generates relatively weak and slow immune responses. Here, we investigated the effect of hepatitis C virus (HCV) antigen modifications on the induction of T-cell responses in DNA immunization. It is likely that the strength of T-cell responses has an inverse relationship with the length of the insert DNA. Interestingly, a mixture of several plasmids carrying each gene induced a higher level of T-cell responses than a single plasmid expressing a long polyprotein. Moreover, the presence of a transmembrane domain in HCV E2 resulted in stronger T-cell responses against E2 protein than its absence. Taken together, our results indicate that the tailored modifications of DNA-encoded antigens are capable of optimizing the induction of T-cell responses which is required for eliminating the cells chronically infected with highly variable viruses such as HCV and human immunodeficiency virus.Keywords
This publication has 40 references indexed in Scilit:
- Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosisGene Therapy, 2003
- Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug usersHepatology, 2002
- Engineering N-glycosylation mutations in IL-12 enhances sustained cytotoxic T lymphocyte responses for DNA immunizationNature Biotechnology, 2002
- Cross-presentation in viral immunity and self-toleranceNature Reviews Immunology, 2001
- Vaccine Development for Hepatitis CSeminars in Liver Disease, 2000
- The Outcome of Acute Hepatitis C Predicted by the Evolution of the Viral QuasispeciesScience, 2000
- DNA immunization of mice and macaques with plasmids encoding hepatitis C virus envelope E2 protein expressed intracellularly and on the cell surfaceVaccine, 1999
- Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α TherapyScience, 1998
- Hepatitis C Virus E2 Protein Purified from Mammalian Cells Is Frequently Recognized by E2-specific Antibodies in Patient SeraPublished by Elsevier ,1997
- Direct Gene Transfer into Mouse Muscle in VivoScience, 1990